Savitz, S. I. et al. (2014) Stem cells as an emerging paradigm in Stroke 3: enhancing the development of clinical trials. Stroke, 45(2), pp. 634-639. (doi: 10.1161/STROKEAHA.113.003379)
Full text not currently available from Enlighten.
Abstract
No abstract available.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Muir, Professor Keith |
Authors: | Savitz, S. I., Cramer, S. C., Wechsler, L., Aronowski, J., Boltze, J., Borlongan, C., Case, C., Chase, T., Chopp, M., Carmichael, S. T., Cramer, S. C., Duncan, P., Finklestein, S., Fischkoff, S., Guzman, R., Hess, D. C., Huang, D., Hinson, J., Kautz, S., Kondziolka, D., Mays, R., Misra, V., Mitsias, P., Modo, M., Muir, K., Savitz, S. I., Sinden, J., Snyder, E., Steinberg, G., Vahidy, F., Wechsler, L., Willing, A., Wolf, S., Yankee, E., and Yavagal, D. R. |
College/School: | College of Medical Veterinary and Life Sciences > School of Psychology & Neuroscience |
Journal Name: | Stroke |
Publisher: | American Heart Association |
ISSN: | 0039-2499 |
ISSN (Online): | 1524-4628 |
University Staff: Request a correction | Enlighten Editors: Update this record